Needham & Company LLC Increases Curaleaf (OTCMKTS:CURLF) Price Target to $6.25

Curaleaf (OTCMKTS:CURLF) had its price target hoisted by Needham & Company LLC from $5.25 to $6.25 in a research note issued to investors on Friday, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock.

Curaleaf Price Performance

Shares of CURLF stock remained flat at $5.50 on Friday. 929,397 shares of the company traded hands, compared to its average volume of 778,184. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.41 and a current ratio of 0.85. The firm’s 50 day moving average is $5.07 and its two-hundred day moving average is $4.51. Curaleaf has a 52 week low of $2.36 and a 52 week high of $6.40.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings results on Wednesday, March 6th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.04. The business had revenue of $345.27 million during the quarter, compared to analysts’ expectations of $336.64 million. Curaleaf had a negative net margin of 20.29% and a negative return on equity of 14.39%. Research analysts predict that Curaleaf will post -0.18 earnings per share for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.